Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.81 USD | -0.36% | +7.60% | +12.73% |
Apr. 18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
Apr. 10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.73% | 852M | |
-1.93% | 103B | |
+0.23% | 95.71B | |
+1.69% | 22.02B | |
-17.03% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.82% | 15.52B | |
+3.59% | 13.86B | |
+34.80% | 12.04B |
- Stock Market
- Equities
- ALXO Stock
- News ALX Oncology Holdings Inc.
- Insider Sell: Alx Oncology Holdings